We are live on ! Find out more
CRL icon

Charles River Laboratories

707 hedge funds and large institutions have $17.7B invested in Charles River Laboratories in 2021 Q4 according to their latest regulatory filings, with 106 funds opening new positions, 245 increasing their positions, 264 reducing their positions, and 64 closing their positions.

New
Increased
Maintained
Reduced
Closed

82% more call options, than puts

Call options by funds: $105M | Put options by funds: $57.7M

66% more first-time investments, than exits

New positions opened: 106 | Existing positions closed: 64

5% more funds holding

Funds holding: 676707 (+31)

0.56% more ownership

Funds ownership: 92.91%93.47% (+0.56%)

7% less repeat investments, than reductions

Existing positions increased: 245 | Existing positions reduced: 264

8% less capital invested

Capital invested by funds: $19.3B → $17.7B (-$1.58B)

25% less funds holding in top 10

Funds holding in top 10: 2015 (-5)

Holders
707
Holders Change
+31
Holders Change %
+4.59%
% of All Funds
10.88%
Holding in Top 10
15
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-25%
% of All Funds
0.23%
New
106
Increased
245
Reduced
264
Closed
64
Calls
$105M
Puts
$57.7M
Net Calls
+$47.4M
Net Calls Change
+$15.9M
Name Holding Trade Value Shares
Change
Change in
Stake
Wells Fargo
26
Wells Fargo
California
$129M +$12.9M +33,138 +11%
Mackenzie Financial
27
Mackenzie Financial
Ontario, Canada
$114M -$1.48M -3,820 -1%
Legal & General Group
28
Legal & General Group
United Kingdom
$114M -$4.54M -11,693 -4%
EAM
29
Eagle Asset Management
Florida
$112M +$203K +523 +0.2%
Dimensional Fund Advisors
30
Dimensional Fund Advisors
Texas
$108M -$33.3M -85,711 -23%
First Trust Advisors
31
First Trust Advisors
Illinois
$106M -$8.55M -22,017 -7%
Charles Schwab
32
Charles Schwab
California
$103M -$123K -316 -0.1%
N
33
Nuveen
North Carolina
$103M +$8.16M +21,013 +8%
Neuberger Berman Group
34
Neuberger Berman Group
New York
$98.8M +$471K +1,212 +0.5%
Fisher Asset Management
35
Fisher Asset Management
Washington
$94.8M +$3.31M +8,521 +4%
Victory Capital Management
36
Victory Capital Management
Texas
$87.5M -$72.1M -185,621 -44%
HKAM
37
Horizon Kinetics Asset Management
New York
$85.6M +$7.58M +19,514 +9%
VBA
38
Van Berkom & Associates
Quebec, Canada
$83.6M -$2.24M -5,765 -3%
T. Rowe Price Associates
39
T. Rowe Price Associates
Maryland
$82.7M -$937K -2,413 -1%
Deutsche Bank
40
Deutsche Bank
Germany
$82.3M -$3.78M -9,725 -4%
Millennium Management
41
Millennium Management
New York
$81.4M -$3.17M -8,166 -4%
Federated Hermes
42
Federated Hermes
Pennsylvania
$80.9M +$5.86M +15,076 +8%
RJA
43
Raymond James & Associates
Florida
$80.5M +$13.1M +33,607 +19%
ESCM
44
Echo Street Capital Management
New York
$80.4M +$12.5M +32,115 +18%
Citadel Advisors
45
Citadel Advisors
Florida
$75.5M +$13.9M +35,873 +22%
Morgan Stanley
46
Morgan Stanley
New York
$75M +$4.49M +11,556 +6%
Swiss National Bank
47
Swiss National Bank
Switzerland
$72.2M -$2.76M -7,100 -4%
Alyeska Investment Group
48
Alyeska Investment Group
Illinois
$71.7M +$30.8M +79,335 +72%
AI
49
Ariel Investments
Illinois
$67.7M -$1.38M -3,558 -2%
EARNEST Partners
50
EARNEST Partners
Georgia
$67M -$3.53M -9,097 -5%

CRL Hedge Fund Activity: Q4 2021 in Review

707 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q4 2021, worth a combined $17.7B — down 8.2% from $19.3B a quarter earlier.

Buyers outnumbered sellers: 106 funds opened new CRL positions and 64 closed out — a net gain of 42 holders — while 245 added to existing stakes and 264 trimmed.

The largest buyer was ClearBridge Investments, adding an estimated $210M. The largest seller was Ameriprise, cutting an estimated $90.1M.

  • 707 institutional investors held Charles River Laboratories (CRL) as of Q4 2021, up from 676 in Q3 2021.
  • Funds reported $17.7B of Charles River Laboratories stock for Q4 2021, down 8.2% quarter-over-quarter.
  • 106 funds opened new Charles River Laboratories positions in Q4 2021 and 64 closed out, a net change of +42 holders.
  • The largest Charles River Laboratories buyer in Q4 2021 was ClearBridge Investments, an estimated $210M added.
  • The largest Charles River Laboratories seller in Q4 2021 was Ameriprise, an estimated $90.1M sold.

Based on aggregated 13F filings for Q4 2021.